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http://dx.doi.org/10.1016/j.pedneo.2Background: The objective of this study was to summarize current information about the
normal values on infant sleep polysomnography for clinical use.
Methods: MEDLINE (Ovid), EMBASE (Ovid), and CINAHL (Ovid) from January 1976 to May 2007
were searched. Two reviewers independently reviewed all relevant articles, using preset inclu-
sion criteria. The population of interest included children aged less than 1 year. Studies in
infants with known major anomalies were excluded. The results on apneas were extracted
and analyzed.
Results: For obstructive apnea, the upper limit of normal values was less than 1.0 per hour,
and for mixed apnea, the current data suggested the upper limit of normal values was less than
1.0 per hour. For central apnea defined as cessation of respiratory efforts for more than 3
seconds, the current data suggested that the upper limit of the normal central apnea index
was 45 per hour for 1-month-old infants, 30 per hour for 2-month-old infants, 22 per hour
for 3-month-old infants, and between 10 and 20 for the older age groups. For the desaturation
episode defined as SpO2 less than 80% for any length of time, the current data suggested the
upper limit of normal values to be 14.7 episodes per hour for day 1, 41 episodes for day 4, and
15.1 episodes for day 39.
Conclusion: The normal values of obstructive apnea, mixed apnea, and central apnea are well
established for neonates and infants. With these normal values, sleep polysomnography study
should be routinely used to quantify the severity of breathing disorders during sleep in those
neonates at risk for these disorders.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.of Paediatrics, Kwong Wah Hospital, Waterloo Road, Hong Kong SAR, China.
(D.K. Ng).
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After delivery, continuous breathing pattern becomes
essential, and it represents a dramatic departure from
fetal life when the breathing movement is irregular.
Hence, it is not surprising that apnea is a common
phenomenon during early infancy. During infancy, apnea is
commonly defined as breathing cessation that lasts for
more than 20 seconds or as a briefer episode if associated
with bradycardia or pallor or cyanosis.1 In the field of
neonatology, apnea is often not routinely differentiated
into central or mixed or obstructive apnea. The use of
polysomnography (PSG) with simultaneous assessment of
multiple relevant variables would help differentiate the
types of apnea. This differentiation might well be impor-
tant for shedding clues as to the underlying etiologies and
prescription of proper treatments, e.g., caffeine for
significant central apnea and continuous positive airway
pressure for significant obstructive apnea. Obstructive
sleep apnea was found in 58% of infants referred to
a single center for apparently life-threatening events
(ALTEs),2 and a population-based case-control study found
that nieces/nephews of patients with obstructive sleep
apnea syndrome (OSAS) were twice as likely as controls to
have offspring who died of sudden infant death syndrome
(SIDS).3 However, an extensive review was published to
address questions about SIDS and its possible relationship
with OSAS and found no strong evidence.3 Hence, the
relationship between ALTEs or SIDS and OSAS remains
controversial. To cast light on this controversy, sleep PSG
appears to be a useful tool. However, the use of PSG in
detecting sleep-related apneas in infants remains difficult
because of the different definitions of apneas used in
different studies, which has resulted in the current lack of
widely accepted normal values for different parameters
recorded in PSG of infants.
In the current review, we analyzed the available data in
the literature on infant sleep PSG parameters in healthy
infants. The primary objectives were (1) to provide infor-
mation about the available normal data on infant sleep PSG
for clinical use and (2) to review the technical specifica-
tions for infant PSG.2. Methods2.1. Sources
The following bibliographic databases were searched:
MEDLINE (Ovid), EMBASE (Ovid), and CINAHL (Ovid), limited
to studies conducted from January 1976 to May 2007. The
keywords used for search included neonate, infant, PSG,
normal, control, healthy, and apnea. The search strategy is
available on request. The search was conducted in May
2007. Standard textbooks in this area were also hand-
searched for additional data.
Bibliographies of review articles, systematic reviews,
and retrieved articles were also searched for candidate
articles. Non-English candidate articles were translated by
a web-based translation engine (Systran, http://www.
systransoft.com/index.html).2.2. Study selection
Case-control, cohort, and epidemiological studies were
retrieved for analysis. Case reports and letters to editors
were not retrieved for analysis. For multiple publications of
the same material, only one article was chosen. Two
reviewers (CCH and DKN) independently reviewed all
pertinent articles, using preset inclusion criteria. Discrep-
ancies were resolved by consensus. Reviewers were not
blinded to the source of publication or authors at any step
during study selection.
2.3. Inclusion criteria
The population of interest included children aged less than
1 year. Studies in infants with known major anomalies (e.g.,
Down syndrome) were excluded. In this review, normal
infants included those who were born at term after
a normal gestation, were not suffering from SIDS or ALTEs,
and have no family history of sleep apnea, SIDS, or ALTEs.
PSG or pulse oximetry was performed in all infants. The
methods of measurement and the number of polysomno-
graphic parameters in all included studies were listed.
Other confounding factorsdi.e., gender of infants, age of
infants, sources of recruitment, and nationalitiesdwere
also listed for each included study.
3. Results
A total of 147 articles met our initial search criteria. Ten
met our primary inclusion criteria. The characteristics of
the included studies are listed in Table 1.
3.1. The configuration of infant PSG
Various signals were recorded to monitor a wide range of
electrophysiological functions in infants during sleep. Most
studies used similar configurations to perform infant PSG
(Table 2). Electroencephalogram (EEG), electrocardiogram
(ECG), electro-oculogram (EOG), thoracic and abdominal
efforts, and oronasal thermistor were used by Kahn,4
Schluter et al,5 Franco et al,6 Rebuffat et al,7 Kato et al,8
and Guilleminault et al.9 Submental and leg electromyo-
gram (EMG) was used by Schluter et al,5 Franco et al,6
Guilleminault et al.9 Either transcutaneous oxygen
monitor or pulse oximeter was used to measure oxygen
saturation. Kahn4 and Schluter et al5 recorded both trans-
cutaneous oxygen tension and pulse oximetry. Actigraph
was recorded by Kato et al,8 Kahn,4 Rebuffat et al,7 and
Franco et al6 to detect infant gross body movement. In the
study by Schluter et al,5 video recording was added.
3.2. Definition of apneas
Contrary to the commonly used definition of apnea in
neonatology,1 apnea was generally defined to last 3
seconds (Table 3). Obstructive apnea was defined as
a continuous activity from a strain gauge that detects
respiratory efforts and flat tracing from thermistors, i.e.,
no air movement. Central apnea was defined as flat tracings
Table 1 Characteristics of studies using polysomnography (PSG) to assess normal values of apneas in normal healthy infants.
First author, year Country Sample PSG and sleep laboratory setting
Schluter, 2001 Germany 354 male and 327 females
1e24 months old
Median gestational age:
39 weeks old (38e40 weeks old)
1 night (time and duration not stated)
Ambient temperature: 20  2C
Humidity: not stated
Sleep position: not stated
Feeding: one feeding and postprandial
period provided
Kato, 2000 Belgium 470 males and 553 females
2e27 weeks old
1 night (8 hours, 2100e0500 hours)
Ambient temperature: 20e23C
Humidity: not stated
Sleep position: not stated
Feeding: on demand
Guilleminault, 1981 United States Age and number of infants
3 wk: 10
6 wk: 10
3 mo: 9
4.5 mo: 10
6 mo: 6
1 night (24 hours, 1100e1100 hours)
Ambient temperature: not stated
Humidity: not stated
Sleep position: not stated
Feeding: not stated
Franco, 2000 Belgium 11 boys and 9 girls
Median age: 11.5 wk
1 night (8 hours, timing not stated)
Ambient temperature: 20C, 25C, 30C
Humidity: not stated
Sleep position: supine
Feeding: on demand
Rebuffat, 1994 Belgium 8 normal infants,
age/gender: not stated
1 night (2100 to 0700 hours)
Ambient temperature: 20e23C
Humidity: 30%
Sleep position: supine
Feeding: on demand
Kahn, 2000 Belgium 1135 normal infants classified
into different age groups
1 night (time not stated, “at least 360 min”)
Ambient temperature: not stated
Humidity: not stated
Sleep position: not stated
Feeding: on demand
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tors. Mixed apnea was defined as central apneas followed
by an obstructive apnea. The study by Guilleminault et al9
separated apneas by duration. The study by Kahn4 defined
central apnea as apnea longer than 4 seconds. Kahn4 also
stated that obstructive events due to displacement of the
thermistors, any doubtful episodes, such as obstructed
breathing preceded by a movement or a sigh, were
rejected.
3.3. Age-related changes in the normal values of
apnea index
The studies conducted by Kato et al,8 Schluter et al,5 and
Kahn4 evaluated the age-related changes in normal values
of polysomnographic variables in infants. All studies re-
ported the normative data on obstructive apnea index (OAI)
and mixed apnea index (MAI). However, the study by Kato
et al8 did not provide the complete data for central apnea.
Downward trends with increasing age were noted in the
90th percentile and 75th percentile curve of obstructive
apnea and mixed apnea. Both obstructive apnea and mixed
apnea indices were highest in the neonatal period. Theduration of obstructive and mixed apneas also tended to
decrease with age. The frequency of central apnea
decreases with age, but the duration was steady at around
3e5 seconds across all age groups.
3.4. Normal values of obstructive apnea
In the study by Schluter et al,5 the median value of OAI
was zero in all age groups. In the study by Kato et al,8
however, the median OAI was 0.15 per hour for 2-week-
old infants and dropped to zero by the time they are 8
weeks old. For the upper limit of OAI, both studies by
Schluter et al5 and Kato et al8 showed a similar decreasing
trend as the infants got older. The 90th percentile of OAI
was 0.65 to 0.78 per hour from 2 weeks onward, and
decreased to a level of 0.25 to 0.48 per hour by 2e3 months
of age. Another study by Kahn4 presented the age-specific
rates of obstructive apnea and mixed apnea per hour of
total sleep up to 27 weeks. The median values of OAI were
zero across all age groups. However, the upper limit (90th
percentile) was not provided in Kahn’s study. It confirmed
the previous observation that pure obstructive apnea was
rarely seen in infants.
Table 2 Configuration of PSG.
First author, year
Schluter, 2001* Different configurations were used during the study period, with following channels: 6 EEG channels,
EOG, EMG, thoracic and abdominal breathing movements by plethysmography, oronasal airflow
(method of measurement was not mentioned), transcutaneous blood gases, oxygen desaturation
as measured by pulse oximeter and ECG.
Kato, 2000 Two EEG with central and occipital leads (C4/A1 and C3/A2), two EOG and ECG. Thoracic respiratory
movements were measured by impedance and airflow with thermistors taped under both nostrils
and on the side of the mouth. Oxygen saturation was recorded continuously by a transcutaneous
sensor (Nellcor, USA). Gross body movements were measured using an actigram placed on one arm.
The data were collected on a computerized infant sleep recorder (Alice Recording
System III, Healthdyne, USA).
Guilleminault, 1981 EEG (C3/A2-C4/A1), EOG, Digastric EMG, ECG lead, Holter ECG, abdominal and thoracic strain gauges,
nasal and oral thermistors, nasal catheter for measurement of percent of CO2 in expired gases,
ear oximeter, skin surface oxygen electrode to measure oxygen tension.
Franco, 2000 2 EEG channels, 2 EOG, digastric EMG, Thoracic respiratory movements were measured by impedance
and airflow with thermistors taped under both nostrils and on the side of the mouth. Gross body
movements were measured using an actigram placed on one arm. Oxygen saturation was recorded
continuously by a transcutaneous sensor. The data were collected on a computerized infant
sleep recorder (Morpheus System, Medatec, Brussels, Belgium).
Rebuffat, 1994 EEG, EOG, ECG, Thoracic respiratory movements were measured by impedance and airflow
with thermistors taped under both nostrils and on the side of the mouth. Gross body movements
were measured using an actigram placed on one arm. Oxygen saturation was recorded continuously
by a transcutaneous sensor. Motion artifacts were detected from body movements and the analysis
of the oximeter waveform. The data were collected on standard polygraph records
(paper speed 10 mm/s) or on computerized systems (Alice III, Apreco, Belgium).
Kahn, 2000 EEG, EOG, ECG, thoracic respiratory movements were measured by impedance and airflow with
thermistors taped under both nostrils and on the side of the mouth. Gross body movements were
measured using an actigram placed on one arm. Oxygen saturation was recorded continuously
by a transcutaneous sensor. Motion artifacts were detected from body movements and the analysis
of the oximeter waveform. The data were collected on standard polygraph records
(paper speed 10 mm/s) or on computerized systems.
Table 3 Definition of apnea in studies.
First author, year Apnea OA CA MA
Schluter, 2001* 3 s Cessation of oronasal airflow
with ongoing respiratory efforts
Cessation of
respiratory efforts
Not clear
Kato, 2000 3 s Continuous deflections from
strain gauges and flat tracing
from thermistors
Flat tracings from both
the strain gauges and the
thermistors
Central apneas followed
by an obstructive apnea
Guilleminault,
1981
Classified into
3e6 s
6e10 s
10e15 s
>15 s
Continuous deflections from
strain gauges and flat tracing
from thermistors
Flat tracings from both
the strain gauges and the
thermistors
Central apnea followed
by an obstructive apnea
Franco, 2000 3 s Continuous deflections from
strain gauges and flat tracing
from thermistors
Flat tracings were obtained
simultaneously from strain
gauges and thermistors
Central apneas followed
by an obstructive apnea
Rebuffat, 1994 3 s Continuous deflections from
strain gauges and flat tracing
from thermistors
Flat tracings were obtained
simultaneously from strain
gauges and thermistors
Central apneas followed
by an obstructive apnea
Kahn, 2000 3 s for
OA and MA
>4 for CA
Continuous deflections from
strain gauges and flat tracing
from thermistors
Flat tracings were obtained
simultaneously from strain
gauges and thermistors
Central apneas followed
by an obstructive apnea
CA Z central apnea; MA Z mixed apnea; OA Z obstructive apnea.
* Different setups of PSG were used during the study period.
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For mixed apnea, the median value of MAI approached zero
across all age ranges in infants studied by Kato et al8 and
Schluter et al.5 For the 90th percentile, both studies showed
similar results, i.e., the MAI was 0.3e0.5 per hour at 2
weeks of life and decreased to 0.2e0.4 per hour by 2e3
months of age. The study by Kahn4 showed that median
values of MAI were zero across all age groups, similar to
OAI. However, the upper limit (90th percentile) was not
provided in Kahn’s study.
3.6. Normal values of central apnea
Schluter et al5 reported the median central apnea index
(CAI) of infants across the neonates from 1 month to 12
months to be 5e10 per hour; they further noted that the
95th percentile of CAI was 45 for 1-month-old neonates, 30
for 2-month-old neonates, 22 for 3-month-old neonates,
and between 10 and 20 for older age groups.
3.7. Effect of ambient temperature of sleep
laboratory on frequency of apneas
Only one study (conducted by Franco et al6) evaluated the
effect of ambient temperature on frequency of apneas in
normal infants. Each infant studied was exposed to the
ambient temperatures of 20C, 25C, and 30C within 1
night. They found that the CAI during rapid eye movement
(REM) sleep was significantly elevated in higher tempera-
tures but not in non-REM sleep. All other frequencies of
respiratory events were similar in either REM or non-REM
sleep.
3.8. First night effect
Only one study7 used PSG to evaluate the night-to-night
variability in apnea indices in normal infants. Out of eight
normal infants studied by Rebuffat et al,7 four had either
mixed or obstructive apneas during the 1st night. The apnea
indices remain comparable in the 2nd night and 3rd night.
3.9. Circadian pattern of distribution in mixed and
obstructive apneas in normal infants
The study by Guilleminault et al9 reported the circadian
pattern of mixed and obstructive apneas in normal infants.
In normal infants, abnormal respiratory events during sleep
were more likely to occur between 1 AM and 6 AM, and more
than 40 minutes after sleep onset.
3.10. Oximetry
Four studies by Stebbens et al,10 O’Brien et al,11 and Poets
et al12,13 reported the median baseline pulse oximetry
(SpO2) and desaturation (defined as SpO2 less than 80%) of
infants using pulse oximetry in the beat-to-beat mode. The
gestational age of infants was at least 37 weeks, and their
median age ranged from 1 hour11 to 191 days13 of life. The
median SpO2 ranged from 97.6% (92e100%)
12 to 98.3%(88.7e100%)11 during the 1st month of life. From 5 weeks to
6 months, the SpO2 ranged from 99.6% (97.9e100%) to 99.9%
(98.6e100%).13 The median rate of desaturation was 0 per
hour (range: 0e14.7) at 1 hour of life.11 On day 4 of life, the
median rate of desaturation was also zero (range: 0e41 per
hour).12 The median rate of desaturation was 0.9 per hour
(range: 0e15.1) for infants on day 39 of life.10 Only one
study11 reported the median duration of desaturation with
and without apnea separately. The median duration of
desaturation without concomitant apnea at 1 hour of life
was 9.3 seconds (0.5e286.8 seconds), and that with apnea
was 0.8 seconds (0.3e89.6 seconds).11 The median duration
of desaturation decreased from 5.1 seconds (4.2e9.9
seconds) at 4 days of life11 to 0.9 seconds (0.4e1.8 seconds)
at 3 months of age.12 Forty-eight percent of desaturation
was associated with concomitant apnea at 1 hour of life.11
Desaturation episodes were more often associated with
apnea with increasing age, and the proportion of desatu-
ration episodes associated with apnea increased from 48%
at 1 hour of life11 to 93.8% at 6 months of age.134. Discussion
In neonatology, apnea is often defined as cessation of
breathing lasting more than 20 seconds.1 However, the
normal value for apnea so defined is not available.
Furthermore, recent evidence suggested that obstruction
of the airway was frequently present in the so-called
central apneas defined as longer than 20 seconds.14 Idiong
et al15 analyzed >4000 apneas in preterm neonates and
found that central apneas occurred predominantly with
durations of less than 10 seconds, whereas apneas >10 s
were usually mixed apneas. It has not been a common
practice to further classify apneas into central, obstruc-
tive, and mixed apneas. For the proper management of
apneas, it would be important to make the distinction even
though the majority (70e80%) of apneas in the neonatal
period would be central apnea.16 PSG would be the ideal
tool to make the distinction and to quantify the abnor-
malities. The current review summarized the available data
about sleep PSG in healthy full-term neonates and infants.
For obstructive apnea, it was clear from current data
that the upper limit of normal values was less than 1.0 per
hour, and neonates with obstructive apnea 1.0 would be
highly suggestive of having a disease that warrants inves-
tigations for the site(s) of obstruction. Data are currently
lacking in the natural course of these obstructive apneas,
and further research is urgently needed.
For mixed apnea, the current data suggested that the
upper limit of normal is less than 1.0 per hour, and those
with mixed apnea 1.0 per hour are suggestive of a disease
state warranting further investigations along the line of
obstructive apnea.
For central apnea defined as cessation of respiratory
efforts for more than 3 seconds, the current data sug-
gested that the upper limit of normal CAI was 45 for
1-month-old infants, 30 for 2-month-old infants, 22 for
3-month-old infants, and between 10 and 20 for older age
groups. For the desaturation episode defined as SpO2 less
than 80%, the current data suggested the lower limit of
normal values to be 14.7 episodes per hour for day 1, 41
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important to realize that the current data were obtained
from pulse oximeter using a beat-to-beat mode, whereas
most commercial pulse oximeters used averaging of data.
Hence, the normal values that are reported may not be
directly applicable to patients monitored with a different
mode. Another important parameter about desaturation
would be the percentage of time spent in each saturation
zone (e.g., SpO2 >90%, between 80% and 90%). Unfortu-
nately, there are currently no normal data on this very
important parameter.
In conclusion, this review summarizes the available
information on the normal values of sleep PSG data of
normal full-term infants for use by clinicians. With these
normal values, sleep PSG study should be routinely used to
quantify the severity of breathing disorders during sleep in
those neonates at risk for these disorders. The normal
oximetry values warrant further research as the current
data addresses only the number of episodes of SpO2 less
than 80% for any length of time. This addresses neither the
length of episode nor the normal value of percentage of
time spent in SpO2 between 80% and 90%.
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